IRIS
PARODI, BRUNELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.281
Totale 11.281
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.281
Totale 11.281
Salva come PNG Salva come JPEG
Città #
Genova 7.914
Rapallo 1.265
Genoa 1.199
Vado Ligure 879
Bordighera 24
Totale 11.281
Salva come PNG Salva come JPEG
Nome #
A focus on mucoadhesive polymers and their application in buccal dosage forms 157
Green extraction from pomegranate marcs for the production of functional foods and cosmetics 152
Chitosan-clodronate nanoparticles loaded in poloxamer gel for intra-articular administration 151
Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-b-cyclodextrin in solution and in the solid state 143
PREPARATION, CHARACTERIZATION AND IN VITRO ANTIVIRAL ACTIVITY EVALUATION OF FOSCARNET-CHITOSAN NANOPARTICLES 138
Complex extemporaneous preparations: stability study of a formulation containing diethylpropion hydrochloride in hard capsules 134
Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino)ethyl 4-amino-benzoate, N4]-chlorideplatinum (II) monohydrochloride monohydrate 134
From pomegranate marcs to a potential bioactive ingredient: a recycling proposal for pomegranate squeezing marcs 134
An example of application of a mixture design with constraints to a pharmaceutical formulation 133
Development and characterization of a mucoadhesive sublingual formulation for pain control: extemporaneous oxycodone films in personalized therapy. 131
Microspheres containing carnosic acid for the treatment of basil fungal diseases 130
An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose 130
Study of retinoic acid polymorphism 126
Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride 126
Buccoadhesive oxycodone hydrochloride disks: plasma pharmacokinetics in healthy volunteers and clinical study 126
STABILITY INDICATING HPLC ASSAY FOR RETINOIC ACID IN HARD GELATINE CAPSULES CONTAINING LACTOSE AND AS BULK DRUG SUBSTANCE 122
Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice. 120
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 119
Median-based robust regression methods in prediction of drug stability 119
Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR. 118
Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation 116
Preparation and evaluation of a chitosan salt–poloxamer 407 based matrix for buccal drug delivery 116
Somatostatin release from rat cerebral cortex synaptosomes 116
"A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid useful for the localization of radionuclides for diagnostic and therapeutic purpose" (PCT deposito) 114
Development, characterization and preliminary clinical evaluation of mucoadhesive vaginal gels containing chlorhexidine digluconate 113
A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraacetic acid useful for the localizationof radionuclides for diagnostic and therapeutic purposes (EP domanda) 113
A Method for the production of bioadhesive compact matrices (European Patent) 112
Compound from Cupuliferae .15. Flavonoid Glycosides from Quercus-Canariensis Willd 111
Identification of degradation products of Ibuprofen arising from oxidative and thermal treatments 111
Stability study of hard gelatin capsules containing retinoic acid 108
A new carrier for cisplatin: nanoparticles deriving from the interaction between N-trimethyl glycol chitosan and poly-L-glutamate 108
Phytotoxic activity of Salvia x jamensis 107
Buccoadhesive polymeric films for oromucosal oxycodone delivery in acute pain control 106
Cisplatin Combined with the new Cisplatin-Procaine Complex DPR : In Vitro and In Vivo Studies 105
Blood and synovial levels of piroxicam and their effects on some metabolites of arachidonic acid 104
A new conjugate of human albumin and p-SCN-Bn-DOTA for radioguided occult lesion localization in breast cancer (ROLL). 104
Cisplatin delivery: a study on a cisplatin-hyaluronate complex and nanoparticles formed by its interaction with N-trimethyl chitosan 103
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (US Patent) 103
A method for the production of bioadhesive compact matrices (Japanese Patent) 103
Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan 102
Flavonoid Glycosides from Quercus-Pubescens-Willd., Quercus-Cerris L. and Quercus-Ilex L.. 101
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex 100
PROCEDE POUR LA FABRICATION DE MATRICES COMPACTES BIOADHESIVES QUI PEUVENT ETRE UTILISEES SOIT EN TANT QUE TELLES, SOIT POUR LA LIBERATION PROLONGEE DE SUBSTANCES ACTIVES ET MATRICES COMPACTES AINSI OBTENUES A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED (Canadian Patent) 100
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 100
A Chitosan-Poloxamer 407 Matrix for Buccal Drug Delivery. 99
A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation 99
Preparation and characterization of PLGA nanoparticles containing demethylfruticulin A from Salvia corrugata Vahl. (Lamiaceae) 99
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED 98
Characterisation and in vitro evaluation of biological activity of retinoic acid complexes with some bile salts 98
Metodo di produzione di matrici compatte bioadesive impiegabili come tali o per il rilascio controllato di sostanze attive e matrici compatte così ottenute. 97
A Hydrophilic Matrix Generated by Direct Compression and Thermal Treatment: Application in Press-Coating 97
Identificazione di nuovi prodotti di degradazione dell'ibuprofene. 96
Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane 96
Chitosan-Alginate Nanoparticles Containing Cisplatin Complexed With Alginate 94
A New Hydrophilic Bioadhesive Matrix for Controlled Drug Release Generated in Direct Compression Tablets by Thermal Treatment: Mechanism Elucidation 94
Preparation of ellagic acid micro and nano formulations with amazingly increased water solubility by its entrapment in pectin or non-PAMAM dendrimers suitable for clinical applications 94
Cytotoxicity and Cellular Accumulation of a New Cis-Diammineplatinum (II) Complex Containing Procaine in Murine L 1210 Cells Sensitive and Resistant to Cis-Diammine dicholoropatinum(II) 93
Preparation and evaluation of N-trimethyl chitosan/alginate nanoparticles containing cisplatin complexed with alginate 92
Evaluation of a new matrix obtained by direct compression and thermal treatment in tablet press-coating 91
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (생체접착성 컴팩트 매트릭스의 제조방법) 91
Preliminary studies on the implementation of polymeric nanoparticles containing clodronate. 88
Solubilization study of retinoic acid employing some bile salts 88
A novel nanoparticulate system based on a new cisplatin-hyaluronate complex and N-trimethyl chitosan 88
Modification of Drug Release from Tablets Produced By direct compression 87
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (China Patent) 87
A Method for the production of bioadhesive compact matrices (Russian Patent) 87
Applicazione del metodo di regressione robusta MBWR nella previsione di shelf life: stabilità di capsule contenenti acido retinoico. 85
Nanoparticles Formed by Interaction of Poly-L-Lysine or Chitosan With Polycarboxylic Polymers Complexed with Cisplatin 85
Chemical and biological properties of a new Cis- diammineplatinum(II) complex containing para-aminobenzoic acid as amino ligand 85
An alternative route of administration of oxycodone:pharmacokinetics and clinical development in cancer pain control 84
Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration. 84
Preformulative study of liposomes containing retinoic acid 82
A Method for the production of bioadhesive compact matrices 82
Aspetti preliminari di uno studio preformulativo riguardante l'acido retinoico. 81
Stabilization studies of chitosan/foscarnet nanoparticles by coating with Poloxamer 407 or glutaraldeyde cross-linking 81
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery Film polimerici mucoadesivi e sistemi a riserva per il rilascio transmucosale di farmaco 80
Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia 80
Cis-Diamminedichloroplatinum (II) - Procaine Pharmacokinetic Interaction in Mice Bearing P388 Leukemia 79
Herbal Mixtures with Claimed Slimming Activity - Determination by TLC and HPLC of Illegally Added Drugs 79
Pharmacokinetics of piroxicam in rheumatoid arthritis:relationship between plasma and synovial levels. 78
Preparation and Characterization of Brushite-Based Bone Cement 78
LONGROLL: a new human albumin conjugate for radioguided localization of non-palpable breast cancer lesion 78
Mucoadesive polymeric films and reservoir devices for transmucosal drug delivery. 77
A water-soluble 1,2-diaminocyclohexaneplatinum(II) complex containing procaine hydrochloride: synthesis and antiproliferative activity in vitro 77
Optimization of a parenteral thermoresponsive formulation based on metformin hydrochloride 76
Gel di fibrina contenenti un complesso cisplatino-ialuronato o nanoparticelle polimeriche da esso derivate per la terapia tumorale locale 75
An experience in mucoadhesive drug delivery 74
Amazing increase of Ellagic Acid solubility by its entrapping into not PAMAM-structured biocompatible dendrimer scaffolds 74
SERUM, URINE AND PERITONEAL FLUID LEVELS OF 5-FU FOLLOWING IP ADMINISTRATION. 73
Preparation and characterization of foscarnet/chitosan nanoparticles 71
FUNCTIONAL INTERACTIONS BETWEEN ALL TRANS RETINOIC ACID AND BILE SALTS ON CELL PROLIFERATION. 71
RESORBABLE BRUSHITE BONE CEMENT WITH CONTROLLED DRUG-RELEASING CAPABILITIES 71
Complessazione dell’acido retinoico mediante sali di acidi biliari: caratterizzazione chimico-fisica e valutazione dell’efficacia antiproliferativa su colture cellulari 70
Development of gel formulations for localized release of metformin 70
Rivestimento con film polimerici di forme di dosaggio buccoadesive 69
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery 69
An insoluble conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (p-SCN-Bn-DOTA) for Radioguided Occult Lesion Localization in Brest Cancer 68
Formulazione bioadesiva per somministrazione boccale di Ossicodone cloridrato 67
Studio di solubilizzazione dell’acido retinoico mediante l’impiego di alcuni sali biliari 67
"Valutazione in vitro della bioadesività di forme di dosaggio boccali" 67
Totale 9.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.257
article - articoli 16.228
book - libri 0
conference - conferenze 12.612
curatela - curatele 0
other - altro 0
patent - brevetti 3.417
selected - selezionate 0
volume - volumi 0
Totale 64.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.020 0 0 0 0 0 283 395 99 184 554 394 111
2020/2021468 29 27 29 31 18 51 16 36 60 56 62 53
2021/20221.460 23 133 95 196 41 75 91 363 54 129 66 194
2022/20231.534 160 104 14 204 221 287 4 114 280 10 120 16
2023/2024819 37 101 19 107 51 251 43 31 39 21 46 73
2024/20251.016 131 168 73 143 278 223 0 0 0 0 0 0
Totale 11.434